Graft-versus-host disease in a child with neuroblastoma after autologous stem cell transplantation

In the pediatric population, hematopoietic stem cell transplantation (HSCT) is used to treat a wide variety of diseases, both malignant and nonmalignant. For many of these diseases, HSCT is a well-established treatment. Acute graft-versus-host disease (GVHD) continues to be a leading cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation. Graft versus host disease is a common complication of allo-SCT which is induced by donor T cell recognition of recipient alloantigens. The occurrence of autologous GVHD suggests that inappropriate recognition of host self-antigens may occur. GVHD in patients who received autologous HSCT is extremely rare compared to patients who received allogeneic HSCT. We present the case of a 4-year-old girl with metastatic neuroblastoma who spontaneously developed autologous GVHD after autologous HSCT.

[1]  T. Anagnostou,et al.  Immune Dysregulation in Autologous Stem Cell Transplant Recipients is Associated with a “Graft Versus Host”-Like Syndrome and Results in Poor Outcomes , 2018 .

[2]  M. Hammami,et al.  Autologous Graft-Versus-Host Disease of the Gastrointestinal Tract in Patients With Multiple Myeloma and Hematopoietic Stem Cell Transplantation , 2018, Gastroenterology research.

[3]  F. Altuntaş,et al.  Treatment of acute graft versus host disease with mesancyhmal stem cells: Questions and answers. , 2016, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[4]  P. Hari,et al.  Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[5]  J. Kaffenberger,et al.  Autologous Graft‐Versus‐Host Disease in a Child with Stage IV Neuroblastoma , 2015, Pediatric dermatology.

[6]  Jae‐Ho Yoon,et al.  Skin Graft-versus-host Disease Following Autologous Stem Cell Transplantation for Multiple Myeloma , 2013, Immune network.

[7]  F. Dazzi,et al.  The immunomodulatory properties of mesenchymal stem cells , 2011, Seminars in Immunopathology.

[8]  P. Hari,et al.  Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma , 2009, Bone Marrow Transplantation.

[9]  W. Leisenring,et al.  Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation. , 2004, Blood.

[10]  E. Farmer,et al.  Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation. , 1987, Archives of dermatology.